US Patent Issued to Dyne Therapeutics on Sept. 22 for "Muscle-targeting complexes and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 24 -- United States Patent no. 12,742,007, issued on Sept. 22, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.).

"Muscle-targeting complexes and uses thereof" was invented by Romesh R. Subramanian (Framingham, Mass.), Mohammed T. Qatanani (Waltham, Mass.), Timothy Weeden (Waltham, Mass.), Jason P. Rhodes (Waltham, Mass.), Cody A. Desjardins (Waltham, Mass.), Brendan Quinn (Boston) and John Najim (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the disclosure relate to complexes comprising a muscle-targeting agent covalently linked to a molecular payload. In some embodiments, the muscle-targeting agent specifically binds to an internalizing cell surface r...